Jump To Top

groundrushairsports

Health News

During the pandemic, colleges and universities across the nation have wrestled with a common dilemma. They wish to open back up for in-person learning but doing so risks increased spread of COVID-19,...

Bupa UK explains the common causes of mouth ulcers We use your sign-up to provide content in ways you’ve consented to and to improve our understanding of you. This may include adverts from us and...

When you have a baby, each pediatrician appointment is filled with endless questionnaires to determine their developmental milestones. Can they smile, are they sitting up, do they point at things? I remember...

Veincentre in Birmingham is delighted to show their support for local charity LoveBrum and as well as donating their £1000 to LoveBrum earlier this year will be donating socks to help the homeless...

  Heart disease. Cancer. Diabetes. Dementia. Researchers spend billions of dollars every year trying to eradicate these medical scourges.
 Yet even if we discover cures to these and all other chronic...

The novel investigational peptide inhibitor zilucoplan (UCB) continues to show promise in the treatment of adults with generalized myasthenia gravis (gMG). Top-line results from the phase 3 RAISE trial...

Five ways to improve your endurance and stamina so you can run without stopping.  Increasing your running stamina unfortunately isn’t the same as increasing your speed. No, no – in order to run...

Rafael Nadal plays tennis against himself in virtual reality game We use your sign-up to provide content in ways you’ve consented to and to improve our understanding of you. This may include adverts...

Individuals with restless legs syndrome showed an increase in symptom severity in the early phase of the COVID-19 pandemic in the United States in 2020, but this increase had waned by 2021, according...

A new study, published today in Alzheimer’s & Dementia, tested whether tadalafil, a drug closely related to Viagra, may be effective in treating people with vascular dementia. The phase II trial,...